Literature DB >> 3335696

Endothelium determines flow-dependent dilation of the epicardial coronary artery in dogs.

T Inoue1, H Tomoike, K Hisano, M Nakamura.   

Abstract

The mechanisms of epicardial coronary artery dilation after reactive hyperemia were studied in instrumented conscious dogs. A pair of ultrasonic crystals, an electromagnetic flow probe and a cuff occluder were placed on the left circumflex coronary artery in 12 mongrel dogs under sterile conditions. Reactive hyperemia after 20 s of coronary occlusion dilated the epicardial coronary artery by 120 +/- 14 micron (3.8 +/- 0.6%, p less than 0.01) from 3.167 +/- 0.345 mm. This reactive dilation was abolished by flow-limiting coronary stenosis. However, vasodilation after nitroglycerin was 168 +/- 26 micron (5.1 +/- 0.5%) and 162 +/- 27 micron (4.9 +/- 0.6%), respectively, before and after flow limitation. After removal of the endothelium by a balloon catheter, dilation of the epicardial coronary artery after reactive hyperemia was markedly attenuated to 7 +/- 4 micron (p less than 0.01 versus before denudation), despite the presence of a similar degree of reactive hyperemia. The extent of coronary dilation after nitroglycerin was unchanged before and after de-endothelialization. Thus, the endothelium contributed to reactive dilation but not to the nitroglycerin-induced dilation. The negative feedback control of coronary diameter to changes in flow velocity may relate to the regulation of coronary artery tone.

Entities:  

Mesh:

Year:  1988        PMID: 3335696     DOI: 10.1016/0735-1097(88)90188-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 2.  Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide.

Authors:  D J Green; G O'Driscoll; B A Blanksby; R R Taylor
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

3.  Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty.

Authors:  T A Fischell; K N Bausback; T V McDonald
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

4.  Value of echocardiography for evaluation of the flow-dependent epicardial coronary vasodilation in vivo.

Authors:  Tianliang Li; Youbin Deng; Lin Wang; Haoyi Yang; Xiaojun Bi; Qingyang Zhang; Jinghua Liu; Qing Chang; Chunlei Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 5.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

6.  Amlodipine induces a flow and pressure-independent vasoactive effect on the brachial artery in hypertension.

Authors:  J L Megnien; J Levenson; M Del-Pino; A Simon
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

7.  Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs.

Authors:  O L Woodman
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

8.  Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.

Authors:  B Ghaleh; J L Dubois-Randé; L Hittinger; J F Giudicelli; A Berdeaux
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Flow-dependent regulation of arteriolar diameter in rat skeletal muscle in situ: role of endothelium-derived relaxing factor and prostanoids.

Authors:  M Friebel; K F Klotz; K Ley; P Gaehtgens; A R Pries
Journal:  J Physiol       Date:  1995-03-15       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.